Severe hepatitis during ketoconazole therapy.

作者: Hidemasa Okumura , Takumi Aramaki , Katsuaki Satomura , Kazuhiro Iizuka , Masao Ohta

DOI: 10.1007/BF02774689

关键词:

摘要: Ketoconazole is an imidazole derivative recently developed as antifungal agent. There have been only a few established cases of hepatotoxicity in the literature. This report describes case presumed ketoconazole characterized by development severe hepatitis with marked centrilobular necrosis. The lack hypersensitivity reactions clinical findings and location necrosis suggested host idiosyncrasy metabolic abnormality effect present case.

参考文章(16)
Jerry R. Mitchell, David J. Jollows, Metabolic Activation of Drugs to Toxic Substances Gastroenterology. ,vol. 68, pp. 392- 410 ,(1975) , 10.1016/S0016-5085(75)80025-4
D. Borelli, J. L. Bran, J. Fuentes, R. Legendre, E. Leiderman, H. B. Levine, A. Restrepo, D. A. Stevens, Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs. Postgraduate Medical Journal. ,vol. 55, pp. 657- 661 ,(1979) , 10.1136/PGMJ.55.647.657
JOHN R GRAYBILL, DAVID J DRUTZ, Ketoconazole: A Major Innovation for Treatment of Fungal Disease Annals of Internal Medicine. ,vol. 93, pp. 921- 923 ,(1980) , 10.7326/0003-4819-93-6-921
D A J Firebrace, Hepatitis and ketoconazole therapy BMJ. ,vol. 283, pp. 1058- 1059 ,(1981) , 10.1136/BMJ.283.6298.1058-D
J K Heiberg, E Svejgaard, Toxic hepatis during ketoconazole treatment. BMJ. ,vol. 283, pp. 825- 826 ,(1981) , 10.1136/BMJ.283.6295.825
ESKlLD A. PETERSEN, Treatment of Chronic Mucocutaneous Candidiasis with Ketoconazole Annals of Internal Medicine. ,vol. 93, pp. 791- 795 ,(1980) , 10.7326/0003-4819-93-6-791
Gerald Medoff, George S. Kobayashi, Strategies in the Treatment of Systemic Fungal Infections New England Journal of Medicine. ,vol. 302, pp. 145- 155 ,(1980) , 10.1056/NEJM198001173020304